MGX - Metagenomi Therapeutics Long-Term Debt

Brandmark of Metagenomi Inc. (MGX)

This daily chart of Metagenomi, Inc. (MGX) long-term liability values is fixed at 0.03. Metagenomi, Inc. (MGX) acts as a pioneer in precision genome editing, investing heavily in the discovery of new CRISPR systems. The business relies on the synergy of artificial intelligence and digital libraries to develop therapies. High-tech laboratories and screening capacities operate at optimal efficiency, ensuring high-quality DNA modification.

Metagenomi, Inc. - MGX Company Long-Term Debts (period 02/21/2024 - 10/31/2026)

Metagenomi, Inc (MGX) - metric breakdowns and financial figures

- current quotes and average value forecast:
Stock Quotes metagenomi.co|MGX - Analyst Consensus Forecast
- market capitalization statistics:
Market Value Metagenomi|MGX - Real Price to Acquire Entire Company
- book capitalization data:
Book Price of a Share Metagenomi|MGX - Book Capitalization|Market Capitalization to Book Value Ratio metagenomi.co|MGX - Company Total Assets
- company total debt and liquidity indicators:
Debt to Capital Ratio Metagenomi, Inc.|MGX - Long-Term Debt to Capital|Current Liabilities to Capital Metagenomi Therapeutics|MGX - Company Debts|Debt to Book Value Ratio Metagenomi|MGX - Company Long-Term Debt|Short-Term Debt Metagenomi|Quick Liquidity Indicator metagenomi.co
- financial results and valuation multiples details:
MGX - Net Profit
Analysis of all company metrics:metagenomi.co - MGX
Core merchandise of Metagenomi

Long-term debt measures the total credit obligations with a maturity of more than one year, allowing an investor to assess capital stability and the issuer's solvency regardless of market volatility. By analyzing the long-term debt structure of the enterprise on GURU.Markets, one can monitor the financial leverage of Metagenomi, Inc. (MGX), which is critical when self-funding the development of DNA editing systems under resource-constrained conditions.

Competitors of Metagenomi, Inc. (MGX)

TEM - Company Long-Term Liabilities|Qiagen - Company Long-Term Debts|Long-Term Debt Ionis Pharmaceuticals, Inc.|RGEN (Repligen Corp.) - Company Long-Term Liabilities|RNA: Amount of Long-Term Liabilities|CRSP (CRISPR Therapeutics AG) - Company Long-Term Debts|Company Long-Term Debts genedx.com|Company Long-Term Debts RARE|Beam Therapeutics Inc (BEAM) - Long-Term Indebtedness|Company Long-Term Debts SRPT (Sarepta Therapeutics Inc)|Twist Bioscience Corp (TWST) - Long-Term Debt|TXG - Company Long-Term Debt|NTLA (intelliatx.com) - Company Long-Term Indebtedness|Stoke Therapeutics, Inc. (STOK) - Company Long-Term Debt|Long-Term Debt BioLife Solutions Inc (BLFS)|Company Long-Term Debt Wave Life Sciences Corp|Company Long-Term Liabilities Maze Therapeutics Corp (MAZE)|Company Long-Term Debts SION|Long-Term Debt Volume primemedicine.com|Taysha Gene Therapies, Inc. - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings QURE|MeiraGTx PLC - Company Long-Term Debts|Long-Term Debt Volume REGENXBIO Corp RGNX|Solid Biosciences Inc. (SLDB) - Company Long-Term Debt|Company Long-Term Indebtedness OCGN|PACB (PacBio) - Company Long-Term Debts|Company Long-Term Liabilities Benitec Biopharma Inc (BNTC)|Company Long-Term Liabilities DSGN (Design Pharma)|Long-Term Debt Volume Rocket Corp|Company Long-Term Debt 4D Molecular Therapeutics FDMT|LXEO - Company Long-Term Liabilities|Korro Bio, Inc - Company Long-Term Debts|Long-Term Indebtedness Editas Medicine Inc (EDIT)|SLN (Silence Therapeutics Inc.) - Company Long-Term Liabilities|Company Long-Term Indebtedness PRQR|CDXS (Codexis Inc) - Company Long-Term Debts|Company Long-Term Indebtedness SGMO (sangamo.com)|Company Long-Term Debt Nautilus Biotechnology (NAUT)|Precision BioSciences Inc. - Company Long-Term Indebtedness|Company Long-Term Debts GBIO (Generation Bio)|Company Long-Term Debts Boundless Bio Inc BOLD|XCUR - Company Long-Term Debt|Imunon, Inc. (IMNN) - Company Long-Term Liabilities|PHIO: Company Long-Term Debts|Long-Term Debt Mustang Bio (MBIO)|Company Long-Term Liabilities RNAZ|BNGO (Bionano) - Amount of Long-Term Liabilities|Company Long-Term Debts APDN|Company Long-Term Debts bluebirdbio.com (BLUE)|Company Long-Term Debts IPA (ImmunoPrecise Antibodies Ltd.)|Long-Term Indebtedness Omega Therapeutics Inc|Singular Genomics Systems Inc - Company Long-Term Debts|Long-Term Debt Regulus|Syros Pharmaceuticals (SYRS) - Company Long-Term Debt|Company Long-Term Indebtedness TBIO|Company Long-Term Debt TRACON Pharmaceuticals, Inc.|Long-Term Debt Unity Biotechnology Inc. UBX